血栓抽吸术联合PCI治疗急性心肌梗死的疗效被引量：3

导出

摘要目的观察血栓抽吸(TA)联合冠状动脉介入术(PCI)治疗急性心肌梗死(AMI)伴有血栓负荷病变的疗效及安全性。方法选取70例(年龄≥65岁)经冠状动脉造影证实冠脉血栓负荷病变患者,在AMI常规治疗基础上均应用盐酸替罗非班治疗,并随机分为TA联合PCI组(45例)和单纯PCI组(25例)。TA联合PCI组加用DiverC.E.血栓抽吸装置。比较两组病人一般发病资料和TIMI血流分级、ST段抬高和回落百分比、心肌显色分级、左心室射血分数(LVEF)、主要心血管不良事件(MACE)。结果两组心肌梗死溶栓治疗TIMI血流分级、ST段抬高和回落百分比(sumSTR)、心肌显色分级(MBG)、LVEF比较具有统计学差异(P<0.05);住院期间TA联合PCI组MACE发生率较单纯PCI组低。结论 TA联合血小板膜受体拮抗剂是治疗AMI伴有血栓负荷病变有效的手段,能够更大程度改善冠脉血流和梗死区域的心肌灌注,挽救濒死心肌,减少MACE事件发生,改善急性ST段抬高型心肌梗死血栓负荷病变患者的左室功能,改善预后。

作者索传涛

机构地区大庆市油田总医院心血管内科

出处《中国老年学杂志》 CAS CSCD 北大核心 2012年第11期2282-2283,共2页 Chinese Journal of Gerontology

关键词血小板膜表面受体拮抗剂心肌梗死冠状动脉介入术

分类号 R541.4 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献4

1Sorajja P,Gersh J,Cox DA,et al. Impact of muhivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction [J]. Eur Heart J ,2007 ;28 (14) : 1709-16.
2孔光明,李贵双,李继福,陈玉国,冯民.国产替罗非班在急性心肌梗死支架置入术中的应用研究[J].中国老年学杂志,2008,28(17):1706-1708. 被引量：4
3Cortese B, Piccchia M. Intra-coronary bivalirudin for no reflow reversal a second chance to treat this disorder [J]. Thrombolysis, 2009 ; 28 ( 1 ) : 74-6.
4刘晓霞,李萌,李学奇.替罗非班对急性冠脉综合征患者血小板CD40L及血清MMP-9水平的影响[J].中国实验诊断学,2010,14(8):1209-1211. 被引量：6

二级参考文献15

1李江,赵水平,彭道泉,周宏年.冠心病患者血清sCD40L和MMP-9的变化及相关性[J].中南大学学报（医学版）,2004,29(5):517-520. 被引量：14
2Hakkinen T,Karkola K,Yla-Herttuala S.Macrophages,smooth muscle cell,endothelial cells,and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions.Colo-calization with epitopes of oxidized low-density liporotein,scavenger receptor,and CD16 (Fc gammar Ⅲ)[J].Virchows Arch,2000,437(4):396.
3Mach F,Schnbeck U,Fabunmi RP,et al.T lymphocytes induce endothelial cell matrix metal-loproteinase expression by a CD40 L-dependentmechanism:implications for tubule formation[J].Am J Pathol,1999,154(1):229.
4Henn V,Steinbach S,Buchner K,et al.The inflammatory action of CD40 ligand(CD154) expressed on activated human platelets is temporally limited by coexpressed CD40[J].Blood,2001,98:1047.
5Garlichs CD,Eskafi S,et al.Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets[J].Heart,2001,86:649.
6Mach F,Schnbeck U,Fabunmi RP,et al.T lymphocytes induce endothelial cell matrix metallo-proteinase expression by a CD40 L-dependentmechanism:implications for tubule formation[J].Am J Pathol,1999,154(1):229.
7Lef kovittz J, Plow EF, Topol EJ. Platelet glycoprotein IIb/ IIIa receptor antagonists trial[ J]. Eur Heart J, 1999 ; I( suppl E) : 18-26.
8Montalescot G, Borentain M, Payor L,et al. Early vs late administ-ration of glycoprotein lib/ Illa inhibition in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction : a meta-analysis [ J]. JAMA ,2004 ;292 ( 3 ) :362-6.
9Chan AW,Chen DP,Bhatt,DL,et al. Long-term mortality benefit with the combination of stents and tirofiban for cardio-genic shock complicatiy after a cute myocardial infardial infarction[ J]. Am J Cardiology,2002 ;89: 132-6.
10Gibson CM, Cannon CP, Daley WL, et al. For the TIMI 4 Study Group. TIMI frame count : a quantitative method of assessing coronary artery flow [ J]. Circulation 1996;93:879-88.